Back to AMLX
Elmind Capital, LP AMLX Position History
Amylyx Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$26M
Q3 2026
Peak value
$26M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1.4M |
| Q1 2026 | $1.6M |
| Q2 2026 | $2M |
| Q3 2026 | $26M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $26M | 894.8K | — | — |
| Q2 2026 | $2M | 112.0K | — | — |
| Q1 2026 | $1.6M | 112.0K | — | — |
| Q4 2025 | $1.4M | 112.0K | — | — |
Other funds holding AMLX
$460.9M
$307.7M
$261.7M
$201.3M
$174.7M
$153.5M